These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36582161)

  • 21. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
    Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
    J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke.
    Poljakovic Z; Supe S; Ljevak J; Starcevic K; Peric I; Blazevic N; Krbot-Skoric M; Jovanovic I; Ozretic D
    Clin Neurol Neurosurg; 2021 Aug; 207():106767. PubMed ID: 34214867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
    Onishchenko LS; Gaikova ON; Yanishevskii SN
    Neurosci Behav Physiol; 2008 Jan; 38(1):49-54. PubMed ID: 18097760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
    Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview.
    Sternberg Z; Schaller B
    Transl Stroke Res; 2020 Apr; 11(2):165-184. PubMed ID: 31327133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.
    Hong Z; Moessler H; Bornstein N; Brainin M; Heiss WD;
    Int J Stroke; 2009 Oct; 4(5):406-12. PubMed ID: 19765131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the effectiveness of neuroprotective therapy in restoring motor function in patients during the acute period of ischemic stroke].
    Minina YD; Zakharov AV; Poverennova IE; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):44-50. PubMed ID: 34693688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials.
    Gao L; Xiao Z; Jia C; Wang W
    Health Qual Life Outcomes; 2021 Mar; 19(1):79. PubMed ID: 33750396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Hoyle CH
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007026. PubMed ID: 32662068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern strategies of protection of hypoxic-ischemic brain damage].
    Yanishevsky SN; Tsygan NV; Golokhvastov SY; Andreev RV; Litvinenko IV; Karpova OS; Yakovleva VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):78-86. PubMed ID: 29411750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.
    Hong JM; Lee JS; Lee YB; Shin DH; Shin DI; Hwang YH; Ahn SH; Kim JG; Sohn SI; Kwon SU; Lee JS; Gwag BJ; Chamorro Á; Choi DW;
    Stroke; 2022 Nov; 53(11):3250-3259. PubMed ID: 36065810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke.
    Zhang C; Chopp M; Cui Y; Wang L; Zhang R; Zhang L; Lu M; Szalad A; Doppler E; Hitzl M; Zhang ZG
    J Neurosci Res; 2010 Nov; 88(15):3275-81. PubMed ID: 20857512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timely and Appropriate Administration of Inhaled Argon Provides Better Outcomes for tMCAO Mice: A Controlled, Randomized, and Double-Blind Animal Study.
    He J; Xue K; Liu J; Gu JH; Peng B; Xu L; Wang G; Jiang Z; Li X; Zhang Y
    Neurocrit Care; 2022 Aug; 37(1):91-101. PubMed ID: 35137354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative aspects of using neuroprotectors in the management of patients with ischemic stroke].
    Ershov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):41-4. PubMed ID: 22224244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL; Clark WM
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):13-8. PubMed ID: 11898495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes.
    Fiani B; Covarrubias C; Wong A; Doan T; Reardon T; Nikolaidis D; Sarno E
    Neurol Sci; 2021 Apr; 42(4):1345-1353. PubMed ID: 33515100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke.
    Guan Y; Li P; Liu Y; Guo L; Wu Q; Cheng Y
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke.
    Chang WH; Park CH; Kim DY; Shin YI; Ko MH; Lee A; Jang SY; Kim YH
    BMC Neurol; 2016 Mar; 16():31. PubMed ID: 26934986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection and stroke rehabilitation: modulation and enhancement of recovery.
    Romero JR; Babikian VL; Katz DI; Finklestein SP
    Behav Neurol; 2006; 17(1):17-24. PubMed ID: 16720957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.